NCT07239869 A Robot-assisted Tailored Activity Programme for People With Dementia and Their Caregivers
| NCT ID | NCT07239869 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 60 participants in total. It began in 2025-09-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the feasibility and preliminary efficacy of the tailored activity programme on improving the physical inactivity of the caregiving dyads.
Eligibility Criteria
Inclusion Criteria for people with dementia: * mild to moderate stage dementia at a standardized mini-mental state examination score (MMSE) higher than 10; * be able to walk independently; * being physically inactive (categorized as "low/inactive" by the International Physical Activity Questionnaire); * free from other medical/functional conditions that would limit physical activity. Exclusion Criteria for people with dementia: * high risk of falling (Berg Balance Scale \<45); * not be suitable for doing physical activity as recommended by the primary care physician; * currently involved in another interventional study involving physical exercise; * had acute hospitalization \>3 times in the past year. Inclusion Criteria for caregivers: * primary informal caregivers who reside with the of the person with dementia; * have provided care for more than six months; * have no intention to send the care recipient to nursing homes in the next six months; * being physically inactive; * use a smartphone. Exclusion Criteria for caregivers: * caregivers with unstable physical or mental conditions; * cannot communicate logically; * not suitable for doing physical activity as recommended by a primary care physician.
Frequently Asked Questions
Who can join the NCT07239869 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07239869 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07239869 currently recruiting?
Yes, NCT07239869 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Hong Kong Polytechnic University to inquire about joining.
Where is the NCT07239869 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07239869 clinical trial?
NCT07239869 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 60 participants.